Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Grip is just growing understandably impatient. When time passes without some type of validation or signal of confidence questions arise.
I am sold on the science as are most here. Seems to be quite special and disruptive. The question is are we close to the tipping point or are we missing something.
It’s been a long haul and I’m in for the end game...are we first and goal at 3 yard line or......well that’s the unknown.
GLTAL’s
LM. I feel your frustration. I’m looking for Pestell to be our articulate voice that has been void. Nader’s responsibilities are being reduced merely because of Pestell’s skill set and I just don’t see Nader getting pushed out coming down the home stretch.
A17,
You are experienced when it comes to biotech and I for the most part feel you bring some contrarian views that are a healthy reminder of the risk that is inherit with this investment.
You are also entitled to your opinion but that’s all it is, however your posts referencing that BP has passed on Pro-140 are written as if they are fact. We all know you are speculating so yes you are going to get the responses from us positive Longs that see it a bit differently.
The fact is nobody knows the reality of what BP is considering or thinking. This is a chess game and we don’t know the moves that have been made or being considered. It only takes one deep pocket to step up and the game accelerates and is over quickly. Pestell joining the team and his comments tell me the tipping point is approaching, the only question is when and how much.
Pro-140 isn’t going to be shelved and ignored by BP forever, the science is simply to safe and disruptive and that’s why Pestell is 100% on board. I’m betting on Pestell’s opinion not yours.
Agreed, I think it was apparent on the last CC that Pestell has no interest in taking the CEO position away from Nader, at least at this juncture. I don’t believe he would have decided to go with CYDY if he wasn’t comfortable and confident working with Nader. Pestell’s presence on the last CC was a glimpse of what’s to come in terms of articulating the Pro-140 story. Much more Pestell pitching to come with Nader doing the catching.
Misiu, Thank you for your clinical insight. I smile every time I read your posts- most of all your humility says much about you as a person.
TT, The low volume substantiates my theory. It will be measured over the coming weeks and months. I’m talking about a shift here in terms of the impact of the Paulson raises. I’ve been here for over five years and participated in three Paulson raises. History has been repeating itself consistently. The tipping point is anybody’s guess. I’m saying the addition of Pestell MAY be creating the initial stages of a tipping point. Yes there are many catalysts in the pipeline that can potentially unlock the SP. As I said we shall see.
The cheap shares are far from drying up. There are plenty out there to bridge to the next wave that is coming from the last raise. The difference now is the likelihood for success has moved up which is curbing the selling. While the pressure still exists the tide may be turning in favor of holding. Pestell changes the landscape. He’s all in and he knows a helluva lot more about the probability of success than any investor. It is logical to think this through before dumping .50 shares that stand a very high probability of being worth many times their current value. We shall see If this theory holds water in the coming weeks and months as more cheap shares become tradable.
Thank you Luv. It’s been a long haul and I’m feeling confident about the next year. Is 2019 finally the year we have been waiting for?
IMO Pestell is going to take us to the end game along with Nader. One thing people don’t recognize is Nader is not the same inexperienced cowboy he was when he first took on this huge undertaking. He is now far more experienced with the FDA and the reality of what it’s going to take to get us to a buy out. I’m not saying he’s now a seasoned pro and the perfect choice to be CEO. Just saying he’s been in the fire for a long time and consequently much more suited today then he was. We all come from somewhere and become somebody. That’s the American dream. My high school buddies wouldn’t have bet that I’d end up as successful as I am.
My hope is Pestell and Nader can put egos aside and utilize each other’s strengths. If Pestell saw Nader as a problem or irremovable he would have passed. I’m thinking they see eye to eye at least right now.
Understand E it’s is not the warrants being sold. It is the ability to keep the risk free warrants and sell the .50 shares that were purchased to gain the right to the warrants. Yes the warrants are the cause of the big blocks that continually halt a run up in the SP however they are simply being held for the end game while dumping cheap shares to eliminate risk. The shares from the recent Paulson raise haven’t hit the market yet but they will. It’s anyone’s guess how much derisking will need to take place to induce Paulson investors to hold their entire stake and quit selling. When that tipping point hits hold on cause it’s going to be a helluva run up.
Nice call on the SA article Chump. I’d say we got exactly what you said we would get.
10m or 27m. I don’t care. In the big picture this was the most we have received in value for 27m shares in the history of this company. Pestell is precisely what this company needed at this juncture to go to the next level. Without him I would remain tossing and turning at night. I’m sleeping much better.
The latest SA article is very unbiased and clearly defines our current status. If we get BLA approval for Combo we are in the money, only question is how much we sell for. I don’t care if it takes another year or two as long as the BK, bag holder, investor loose it all likelihood is taken off the table. BLA approval does just that IMO.
The future is brighter than it has ever been in CYDY land.
If anybody thinks 27M shares was too much to bring Pestell and his life’s work to CYDY then ask this question:
How confident would you be with Nader running the entire show and all our eggs in the HIV basket?
I for one am sleeping a whole lot better knowing we have a very polished scientist that can articulate the multifaceted value of Pro-140 and he’s all in - he’s saying I’m willing to bet it all on Pro-140. That’s enough for me. Now we wait and watch Pestell change the face of Pro-140 and attract fresh investment opportunities. For starters a licensing deal that can send Paulson packing.
I’m just calling it the way I see it. The science seems to be quite compelling, however the SP and the current lack of interest by BP, financing options, etc., indicates otherwise or at the very least not compelling at this moment. Does that mean Pro-140 is worthless. Absolutely not.
It means until financing is resolved here we sit from a value standpoint and the advancement of Pro-140 moving at a snails pace. The continuation of warrant driven Paulson raises indicate the level of interest and value the market places on Pro-140. Nader, who knows the Pro-140 story better than anyone is unable to articulate and market what seems to be a very valuable and unique molecule.
IMO, BP is happy to sit back and chuckle as Nader stumbles with his brash overconfident style that up to this point can only attract loan shark financing. I firmly believe in the strength and value of Pro-140 more than ever. On the other hand my patience and belief that Nader can get us over the financing dilemma is wearing thin. I am very patient but after witnessing his defensiveness and inability to articulate the story for five plus years my confidence has deteriorated.
I’m willing to give him one last chance through the end of the year with the Pestell and Klump move to straighten out financing and move the needle. If not it is clear that he needs to move out of the way. Hopefully this will happen naturally with Pestell stepping up and repackaging the strength of Pro-140.
The definition of insanity is doing the same thing over and over again and expecting a different result.
AIMHO My fellow long investors.
Couldn’t agree more. You will get nada in terms of answers to your questions. I hope I am wrong but I’ve been down that road multiple times.
At this point in Pro-140’s development the word from Gilead is you got nothing. They aren’t jumping at another Combo option regardless of Pro-140’s safety profile.
Mono would be a different story. Nader knows this and is ramping to the higher dosage to hopefully grab some serious attention with 80-90% Efficacy while maintaining a strong safety profile. The question here that everyone is asking is the same one I want answered (besides financing) where are we with the 700ml dosing? Are we moving or stagnant due to lack of $? Time is $ and at this pace it’s going to be years and a different market place in terms of competition.
When Tony C quietly disappeared with the addition of Pestell the company shifted to the Cancer story with Pestell to attract new investors. That was the only way to raise money with Paulson because the HIV well was dry. Will Pestell along with Klump change the financing picture and free us from Paulson? I’m hopefully optimistic.
Personally I don’t believe anything Nader has to say until it’s fact. Especially when it comes to financing.
Golden-LMAO. You completely pegged Nader.
Thx for clarifying Luv. People just don’t understand the entirety of the Paulson raises. Warrants are the drag on SP. Exclusivity of participation also contributes, size of raise, etc., etc. The big picture is the impact of finalizing Pestell agreement, and ultimately ability to get a major financing deal.
Seriously Terd. All coherent investors are eager to here logical posts. Thank you Tony. All points are valid. The truth awaits.
I do have warrants at .75 expiring in October. SP would have to be well above $1 to entice me to exercise.
Stock wants to run up and oh boy would it.
If the raise were to be without warrants it would be a surprise and send a message that the party is over for free riding investment here at the Nader ranch.
Then we would be on our way to true valuation because shares purchased through Paulson would have real value.
We all know the likelihood of this happening with the current raise is close to zero.
Paulson raises are like the movie Groundhog Day starring Bill Murray.
I don’t know. As is the case with many here I have participated in multiple warrant driven Paulson raises dating back to Oct 2013. My frustration is the assurance and confidence I received from management that we were done with Paulson when Tony C took over and even prior for that matter. They were very confident that the strength of the trials would increase SP and attract alternative financing that would allow the market to operate freely in terms of Pro-140’s real valuation. Instead we have been left with loan shark financing that rapes and controls SP. I can tell you management really believed hitting Combo PE was going to move the SP big time. IMO it would have been a major event if the trial had run smoothly instead of being delayed close to two years- that was costly to say the least. The question now is at what point will the derisking of Pro-140 get a guy like Klump to step up, Or BP to move, to free us from Paulson?
Playing the Pestell Cancer Card along with Klump creates a new story that Paulson can spin to attract new investors. Something they had to do as the HIV story was drying up for Paulson. It is clear that by adding Pestell and Klump they are hoping to break the Paulson cycle. What’s disappointing is that the story is running through Paulson rather than another channel.
The market is waiting for financing to validate the science as am I.
It’s simple for me. I have had numerous conversations with Nader, Tony C, and others on the board over the years and the story has always been we are almost to pay dirt. The only pay dirt we have been getting is Paulson, Paulson, Paulson. We can only go to the well so many times with Paulson before it is dry because people like myself will only write the check so many times regardless of who Nader does the the D&P show with.
Don’t get me wrong I couldn’t be more excited about the addition of Pestell’s cancer background and Klump’s financing possibilities because I am hopeful the road we have been on for too long may finally redirect.
I will refrain from the let down of so many disappointments and promises until the check is written. Show us the money so the science can be unleashed.
Correction. Because it’s the same Nader/Paulson dance.
No it’s not because it’s the same Nader/Paulson dance. Until substantive financing is secured this is the dance we will do at a warrant driven SP. Science is becoming increasingly compelling, where are the deep pockets to validate the science?
Time, the greatest equalizer has eased the frustration as I’ve had plenty of time to gain perspective. At this point I’ve pretty much given up on the .75 warrants that will expire the end of October. I have talked to Nader and Tony C a number of times over the years about my growing concern that progress was continually being delayed and that if it continued the October 2018 warrants would be dead. They both were quite optimistic that we’d all be long gone. So for me until Nader (who is back in the power position) delivers with a rock solid PR I’m paying little attention. I too have a big position with plenty more warrants staggered with what one would think is plenty of time. We will see. The science story allows me to get to sleep at night while management makes it difficult to get back to sleep when the prostate comes calling in the wee hours of the night.
Exactly right BioTech.
The warrants are staggered all over the board with 5 year expiration’s. I have my first placement expiring the end of October. I would have never thought we’d go this long before a buy out. Unfortunately if the SP doesn’t appreciate rapidly I will be foregoing my October warrants. The upside is there will be approx. seven million warrants flushed. Downside is no $ raised.
Our future, as the board has clearly defined rests on long term financing as the science is solid and extremely compelling with the addition of Pestell and the cancer play. Having seen and heard the enthusiastic Nader for a very long time I will believe it only when a PR validates and confirms that warrantless serious financing has been procured.
Personally I have settled into the endurance stage of this investment as day to day observations while insightful are pure speculation and taxing on the mind. Many here will have earned the grand slam if it comes to fruition
Come on Nader show us the meat.
Those that sign an NDA are not allowed to purchase or sell shares on the open market until the information
is made pubic.
Oops my bad. Lol
What we personally think Pestell’s value is to CYDY has no impact on the way this will play out. That isn’t to say I don’t care what we pay for Pestell. The fact is Nader and management will cut what they deem to be the best deal- obviously he doesn’t want to give any more than he has to but it appears we not only need Pestell for financing but also if we are serious about the cancer play.
What matters at this moment is Pestell’s ability to attract long term warrant free financing so the advancement of Pro-140 can be expedited and the SP can appreciate without warrant manipulation. If he can accomplish that give him a nice chunk. Then more chunks for meeting milestones on his cancer gig. Pro-140 is for the moment incarcerated waiting for bail to be paid. My hope is Pestell can arrange bail with favorable terms.
.75
Incredible science, sky’s the limit, however dependent on financing. We shall see if Nader, the promoter can pull the proverbial rabbit out of the hat. Pisses me off we have been backed into a corner financially with how far we have come.
I have warrants that expire In October. Never thought I’d be in this venture this long. I’m sure as hell not going to bail at this juncture. I’m in all the way.
My take, the science will prevail- ROI is anybody’s guess at this point.
Great story Rwshay. Thanks for sharing.
CYDY #25 most read IHUB Boards.
https://investorshub.advfn.com/boards/most_read.aspx
It’s not about saying no to 50% efficacy and that Pro-140 would have no value as a mono therapy. 70% efficacy is important because that’s the number I have heard the FDA set to convert from Investigational to Pivotal Trial. IMO if FDA gives green light to convert to Pivotal and also were to grant BTD buy out will happen quickly.
Trding, I don’t have private message. Just wanted to say thank you.
I agree regarding all posts referencing AF. A scumbag that appears to have lost some of his power... and that’s a good thing. He cost me 700k also on a stock with a perfectly timed super negative slant in the Street. That was an expensive lesson.
When AF takes notice it’s a good thing and a bad thing. Means your on the map and being noticed. He bashes small biotech’s on the move. If you really get going he will get his followers on the same page and attempt to lay a bear trap. Seen him send a company up from $2 to $6 in a week and pull the plug and tank the stock to under $2 in one day with a crafty negatively written piece and he sends it through all channels. Idiot, ego maniac or not he has power. Just need to know he’s prowling around.
Your math makes no sense. End of story.
A17, I understand your reasoning for a new Mono Pivotal Trial because of increased dosage safety but I don’t agree.
There is a reason why enrollment continues with the current Mono investigational trial. They are upping the dosage in this trial from 350ml to either 525ml or 700ml. This didn’t start yesterday - my understanding is it’s been going on for quite some time. So let’s run this out six months and we’ve got 200 more patients on increased dosage and the ongoing safety data. Let’s say the efficacy is running at an 80% clip with STILL no safety red flags. How in your right mind do you think the FDA is going to come back and say start a new Pivotal with the same protocol except make every patient go on 525ml-700ml dosage so we can double check safety?
Number one Nader would discontinue enrollment today if that was the case because he’d be throwing $ down the toilet on needless data. Nader is not stupid and he’s the one dealing directly with the FDA, not you. Your absolutely trying to throw a wet towel on this and I think your smarter than the proposed logic your posting.
Could your scenario play out? Yes, just like Southern California could get 50 inches of rain next year. Tell me what I’m missing because it just doesn’t add up.
Spot on BD. A17 has been around the block when it comes to Biotech. He knows a helluva lot more than I do about the whole process. I would never block out of difference of opinion. We need to have our eyes wide open as nothing is ever exactly as it seems.
I have listened and yes I’m impressed. He certainly adds credibility and value.